查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1901521

移植診斷市場依產品類型、技術、應用、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025-2032年預測

Transplant Diagnostics Market by Product Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年移植診斷市場規模為 62.6798 億美元，從 2025 年到 2032 年將以 7.5% 的複合年成長率成長。

全球移植診斷（TD）市場正經歷強勁成長，這主要得益於末期器官疾病盛行率的上升，進而推動了全球器官和幹細胞移植手術數量的增加。該市場主要關注人類白血球抗原（HLA）分型、抗體檢測和移植後監測，以確保供體與受體的相容性並最大限度地減少移植排斥反應。技術進步，特別是下一代定序（NGS）和供體來源的遊離DNA（dd-cfDNA）檢測，正在透過提供高解析度的配型和非侵入性排斥監測，改變診斷格局。這些創新方法正在改善患者預後，並擴大診斷平台在醫院和專業參考實驗室的臨床應用範圍。先進診斷平台的高昂成本和持續的器官短缺仍然是限制市場發展的關鍵因素。

移植診斷市場－市場動態

分子檢測技術進步

技術進步是推動這一趨勢的關鍵因素，主要體現在從血清學和基於PCR的檢測方法轉向高解析度定序技術的轉變。例如，2023年10月，美國GenDx公司推出了NGS-Turbo，這是一款旨在革新高解析度HLA分型的新一代解決方案。該產品利用牛津奈米孔技術公司的定序平台，提供快速、準確且可擴展的分型結果，顯著縮短了周轉時間，並增強了移植診斷中的相容性評估。採用下一代定序（NGS）進行HLA分型至關重要，因為它可在等位基因層面上提供無與倫比的解析度，從而實現更準確的供體-受體匹配，並顯著降低移植物抗宿主疾病（GVHD）和排斥反應的風險。此外，利用分子檢測方法進行非侵入性監測（例如定量受體血液中的dd-cfDNA）可為同種異體移植損傷提供早期、可靠的生物標記物，從而推動臨床管理向個人化醫療策略發展。研發資金的增加和這些尖端檢測方法的法規核准的利好，加速了這一趨勢。

移植診斷市場細分分析：

全球移植診斷市場按產品類型、技術、應用、最終用戶和地區進行細分。

依產品類型，市場分為三大類：試劑及耗材、儀器以及軟體及服務。由於移植手術數量龐大，且對專用HLA分型試劑盒、檢測抗體和核酸萃取試劑的需求持續存在，因此試劑及耗材類市場佔有率最大。

根據技術分類，市場可分為兩大類：分子檢測和非分子檢測及其他檢測。分子檢測，包括基於PCR和測序（NGS、Sanger測序）的方法，因其卓越的準確性和高通量能力（對於解析複雜的HLA等位基因至關重要）而佔據市場主導地位。非分子檢測包括血清學檢測和混合淋巴細胞培養（MLC）檢測。

根據應用領域，市場可分為兩大類：診斷應用（移植前診斷、移植後監測）、研究應用和其他應用。診斷應用是主導領域，其主要驅動力是強制性的移植前相容性檢測。

根據最終用戶，市場可分為三大類：醫院和移植中心、診斷實驗室以及研究和學術機構及其他。診斷實驗室（包括獨立參考實驗室）憑藉其高通量處理能力和複雜分子檢測的專業知識，佔據了相當大的市場佔有率。

移植診斷市場—地域洞察

北美佔據最大的市場佔有率，這主要歸功於其完善的醫療基礎設施、對先進診斷技術的高度認知以及大量的器官移植手術，尤其是腎臟和心臟移植。歐洲緊隨其後，這得益於標準化的器官共享計畫（如歐洲移植中心）以及對醫療研究的大力公共投入，從而促進了非侵入性監測系統的早期應用。亞太地區預計將成為成長最快的市場，這主要得益於醫療支出的快速成長、慢性病發病率的上升以及政府支持器官捐贈計畫的政策不斷完善，尤其是在中國和印度等國家。拉丁美洲和中東及非洲地區的成長較為緩慢但穩定，主要受制於醫療體系分散和技術成本高昂，不過政府的策略性投資正在創造市場機會。

移植診斷市場—國家/地區洞察

中國人口基數龐大，近年來器官捐贈體系的監管取得了顯著進展，因此有望成為高潛力市場。中國大幅擴大了自願捐贈器官計劃，導致器官移植數量激增，對精準移植診斷的需求也隨之飆升。推動這一成長的關鍵因素包括政府推行醫院基礎設施現代化、大力投資國內分子診斷研發，以及自動化、高通量HLA分型系統（通常是本地生產或改造的）的日益普及。然而，該市場也面臨許多挑戰，例如如何統一不同地區醫院的檢測流程，以及如何解決解讀複雜NGS資料所需的高素質專業人員短缺的問題。為了適應監管框架，市場進入策略通常需要與當地企業建立合作關係。

目錄

第1章：移植診斷市場概覽

  • 研究範圍
  • 市場估算年份

第2章：執行概要

  • 市集
  • 競爭洞察

第3章：移植診斷市場主要趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場未來趨勢

第4章：移植診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景分析
  • 規範架構分析

第5章：移植診斷市場：地緣政治緊張局勢升級的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：移植診斷市場概況

  • 移植診斷市佔率分析，2024 年
  • 主要製造商細分數據
    • 知名球員分析
    • 新興參與者分析

第7章：移植診斷市場：依產品類型分類

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 試劑和耗材
    • 儀器
    • 軟體與服務
    • 其他

第8章：移植診斷市場：依技術分類

  • 概述
    • 細分市場佔有率分析：依技術分類
    • 分子檢測
      • 基於PCR的檢測
      • 基於定序的檢測方法（NGS、Sanger測序）
    • 非分子檢測
      • 血清學檢測
      • 混合淋巴球培養（MLC）
    • 其他

第9章：移植診斷市場：依應用領域分類

  • 概述
    • 細分市場佔有率分析：按應用
    • 診斷應用
      • 移植前診斷（HLA分型、交叉配對）
      • 移植後監測（排斥/感染）
    • 研究應用
    • 其他

第10章：移植診斷市場：依最終用戶分類

  • 概述
    • 細分市場佔有率分析：按應用
    • 醫院及移植中心
    • 診斷實驗室（獨立參考實驗室）
    • 研究與學術機構
    • 其他

第11章：移植診斷市場：依地域分類

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • その他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • その他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • その他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • その他

第12章：主要供應商分析：移植診斷產業

  • 競爭格局分析
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • CareDx, Inc.
    • Immucor, Inc. (part of Werfen)
    • Illumina, Inc.
    • Qiagen NV
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Omixon Ltd.
    • Eurofins Scientific SE
    • Others

第13章：全面展望

簡介目錄
Product Code: ANV5901

The Transplant Diagnostics Market size was valued at US$6,267.98 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

The global Transplant Diagnostics (TD) market is experiencing robust growth driven by the rising number of organ and stem cell transplantation procedures worldwide due to the increasing prevalence of end-stage organ diseases. The market primarily focuses on Human Leukocyte Antigen (HLA) typing, antibody detection, and post-transplant monitoring to ensure donor-recipient compatibility and minimize graft rejection. Technological advancements, particularly in Next-Generation Sequencing (NGS) and donor-derived cell-free DNA (dd-cfDNA) testing, are transforming the diagnostic landscape by offering high-resolution matching and non-invasive rejection monitoring. These innovative approaches are improving patient outcomes and expanding the clinical utility of diagnostic platforms across hospitals and specialized reference laboratories. The high cost of advanced diagnostic platforms and a persistent organ shortage remain key constraints.

Transplant Diagnostics Market- Market Dynamics

Technological Advancements in Molecular Assays

Technological progress is the paramount driver, primarily through the shift from serological and PCR-based assays to high-resolution sequencing technologies, for instance, On October 2023, GenDx (U.S.) introduced NGS-Turbo, a next-generation solution designed to transform high-resolution HLA typing. The launch leverages Oxford Nanopore Technologies' sequencing platforms to deliver rapid, accurate, and scalable typing results, significantly improving turnaround time and enhancing compatibility assessment in transplant diagnostics. The adoption of Next-Generation Sequencing (NGS) for HLA typing is critical as it offers unparalleled resolution at the allele level, leading to more accurate donor-recipient matching and significantly reducing the risk of graft-versus-host disease (GVHD) and rejection. Furthermore, the development of non-invasive monitoring using molecular assays, such as quantifying dd-cfDNA in the recipient's blood, provides an early, reliable biomarker for allograft injury, moving clinical management towards personalized medicine strategies. This trend is accelerated by increasing R&D funding and favorable regulatory approvals for these cutting-edge tests.

Transplant Diagnostics Market- Segmentation Analysis:

The Global Transplant Diagnostics Market is segmented on the basis of Product Type, Technology, Application, End-user, and Region.

The market is divided into three categories based on Product Type: Reagents & Consumables, Instruments, and Software & Services. The Reagents & Consumables segment holds the largest share due to the high volume of transplant procedures and the recurring need for specialized HLA typing kits, detection antibodies, and nucleic acid extraction reagents.

The market is divided into two major categories based on Technology: Molecular Assays and Non-Molecular Assays and others. Molecular Assays, encompassing PCR-based and Sequencing-based (NGS, Sanger) methods, dominate the market due to their superior accuracy and high throughput capability essential for resolving complex HLA alleles. Non-Molecular Assays include Serology and Mixed Lymphocyte Culture (MLC) tests.

The market is divided into two categories based on Application: Diagnostic Applications (Pre-transplant Diagnostics, Post-transplant Monitoring) , Research Applications and others. Diagnostic applications are the dominant segment, driven by mandatory pre-transplant compatibility testing.

The market is divided into three categories based on End-user: Hospitals & Transplant Centers, Diagnostic Laboratories, and Research & Academic Institutes and others. Diagnostic Laboratories, including independent reference labs, hold a substantial share due to their high-volume processing capabilities and specialized expertise in complex molecular assays.

Transplant Diagnostics Market- Geographical Insights

North America commands the largest market share, attributable to its sophisticated healthcare infrastructure, high awareness of advanced diagnostic technologies, and a large number of transplant procedures, especially kidney and heart transplants. Europe follows closely, driven by standardized organ sharing programs (like Eurotransplant) and robust public funding for healthcare research, promoting early adoption of non-invasive monitoring systems. The Asia Pacific (APAC) region is projected to be the fastest-growing market, fuelled by rapid improvements in healthcare spending, an increasing incidence of chronic diseases, and evolving government policies that support organ donation programs, particularly in countries like China and India. LATAM and MEA regions exhibit slower, steady growth, primarily constrained by fragmented healthcare systems and high technology costs, though strategic governmental investments are beginning to create market opportunities.

Transplant Diagnostics Market- Country Insights

China is poised to be a high-potential market due to its sheer population size and the significant recent regulatory advancements in its organ donation system. The country has substantially increased its voluntary deceased donor program, leading to a rise in transplant volumes and a corresponding spike in the demand for accurate transplant diagnostics. Key drivers include government initiatives to modernize hospital infrastructure, massive investments in domestic molecular diagnostics R&D, and the increasing adoption of automated, high-throughput HLA typing systems, often locally manufactured or adapted. However, the market faces challenges related to standardizing testing protocols across diverse regional hospitals and addressing the shortage of highly specialized personnel required to interpret complex NGS data. Market entry strategies often involve local partnerships to navigate regulatory frameworks.

Transplant Diagnostics Market- Competitive Landscape:

The global transplant diagnostics market is highly competitive and moderately consolidated, dominated by key players such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., CareDx, Inc., Immucor, Inc. (part of Werfen), Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Abbott Laboratories, Omixon Ltd., and Eurofins Scientific SE. These companies focus heavily on molecular assay platforms, where competition centers around the resolution and speed of HLA typing, sensitivity of antibody detection, and the development of non-invasive graft rejection monitoring tools like dd-cfDNA. Key strategies include Mergers & Acquisitions (M&A) to acquire novel technologies, notably the integration of bioinformatics software for enhanced data interpretation. Companies are aggressively pursuing strategic collaborations with major transplant centers and reference laboratories to expand their product penetration and establish clinical validation for new assays. A prominent trend is the shift towards integrated solutions that combine instruments, reagents, and analytical software into a single, seamless workflow for improved lab efficiency. For example, in October 2025, a leading diagnostics firm acquired a specialized AI-driven platform provider to enhance predictive modeling for post-transplant infection risk.

Recent Developments:

On February 2025, Pirche AG (Germany) entered into a strategic partnership with Devyser AB (Sweden) to advance next-generation transplant diagnostics. The collaboration focuses on integrating Pirche's AI-driven TxPredictor Platform-designed for immune profiling and risk prediction-with Devyser's portfolio of novel biomarkers to enable more personalized monitoring in transplant patients. This combined approach aims to enhance clinical decision-making by improving compatibility assessment, early rejection detection, and overall transplant outcomes.

On May 2024, Thermo Fisher Scientific launched a CXCL10 testing service developed for kidney transplant patients. This advanced assay enables rapid detection of the CXCL10 chemokine, offering faster results compared to currently used diagnostic methods. By improving early identification of inflammatory activity and potential rejection, the service enhances clinical decision-making and supports more effective post-transplant monitoring.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TRANSPLANT DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • Immucor, Inc. (part of Werfen)
  • Illumina, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Omixon Ltd.
  • Eurofins Scientific SE
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032

  • Reagents & Consumables
  • Instruments
  • Software & Services
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032

  • Molecular Assays
  • PCR-based Assays
  • Sequencing-based Assays (NGS, Sanger)
  • Non-Molecular Assays
  • Serological Assays
  • Mixed Lymphocyte Culture (MLC)
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Applications
  • Pre-transplant Diagnostics (HLA Typing, Cross-matching)
  • Post-transplant Monitoring (Rejection/Infection)
  • Research Applications
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Transplant Centers
  • Diagnostic Laboratories (Independent Reference Labs)
  • Research & Academic Institutes
  • Others

GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Transplant Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Transplant Diagnostics Market Snippet by Product Type
    • 2.1.2. Transplant Diagnostics Market Snippet by Technology
    • 2.1.3. Transplant Diagnostics Market Snippet by Application
    • 2.1.4. Transplant Diagnostics Market Snippet by End-user
    • 2.1.5. Transplant Diagnostics Market Snippet by Country
    • 2.1.6. Transplant Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Transplant Diagnostics Key Market Trends

  • 3.1. Transplant Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Transplant Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Transplant Diagnostics Market Opportunities
  • 3.4. Transplant Diagnostics Market Future Trends

4. Transplant Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Transplant Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Transplant Diagnostics Market Landscape

  • 6.1. Transplant Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Transplant Diagnostics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Instruments
    • 7.1.4. Software & Services
    • 7.1.5. Others

8. Transplant Diagnostics Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
    • 8.1.2. Molecular Assays
      • 8.1.2.1. PCR-based Assays
      • 8.1.2.2. Sequencing-based Assays (NGS, Sanger)
    • 8.1.3. Non-Molecular Assays
      • 8.1.3.1. Serological Assays
      • 8.1.3.2. Mixed Lymphocyte Culture (MLC)
    • 8.1.4. Others

9. Transplant Diagnostics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 9.1.2. Diagnostic Applications
      • 9.1.2.1. Pre-transplant Diagnostics (HLA Typing, Cross-matching)
      • 9.1.2.2. Post-transplant Monitoring (Rejection/Infection)
    • 9.1.3. Research Applications
    • 9.1.4. Others

10. Transplant Diagnostics Market - By End-user

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 10.1.2. Hospitals & Transplant Centers
    • 10.1.3. Diagnostic Laboratories (Independent Reference Labs)
    • 10.1.4. Research & Academic Institutes
    • 10.1.5. Others

11. Transplant Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Transplant Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Transplant DiagnosticsKey Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.13.6. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Transplant DiagnosticsKey Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.15.3. PhilippinesMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Transplant Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Transplant DiagnosticsKey Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
    • 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
    • 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.9. UAE
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.9.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.9.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.9.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.9.6. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)

12. Key Vendor Analysis- Transplant Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific Inc.
    • 12.2.2. Bio-Rad Laboratories, Inc.
    • 12.2.3. CareDx, Inc.
    • 12.2.4. Immucor, Inc. (part of Werfen)
    • 12.2.5. Illumina, Inc.
    • 12.2.6. Qiagen N.V.
    • 12.2.7. F. Hoffmann-La Roche AG
    • 12.2.8. Abbott Laboratories
    • 12.2.9. Omixon Ltd.
    • 12.2.10. Eurofins Scientific SE
    • 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us